TIMP-1 was reported to inhibit both MMP-2/9 activities in line [19], therefore the inhibition of MMP-2 activities in human hepatocellular carcinoma cells exposed to genipin may be attributable to up-regulation of TIMP-1. The gene discussed is MMP2; the disease is hepatocellular carcinoma.